BackJounce Therapeutics Overview

Jounce Therapeutics Research & Development

Research & Development expenses for JNCE.

Quarterly R&D Expenses

$23.20M
↓ 100117.24% YoY

As of Dec 31, 2022

Annual R&D Expenses (TTM)

$103.27M
↑ 56.78% YoY

Trailing 12 months ending Dec 31, 2022

Average R&D Expenses (Comparison Companies)

Research & Development History

Research & Development Comparison

Annual Research & Development Growth Rate (%)

Annual Research & Development Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin